Patents Examined by John D Alexander
  • Patent number: 7089055
    Abstract: An apparatus and method is presented for improving cardiac function after successful termination of a tachyarrhythmia such as ventricular fibrillation. A series of electrical stimulation pulses are delivered prior to a defibrillation shock if one or more specific criteria are met.
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: August 8, 2006
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Adam W. Cates, Eric G. Lovett, Douglas J. Lang
  • Patent number: 7029443
    Abstract: T-wave amplitude and QT interval are derived from patient cardiac signals. Then blood glucose levels are determined based on a combination of the T-wave amplitude and the QT interval. By using a combination of both T-wave-based and QT interval-based signals, blood glucose levels can be reliably detected throughout a wide range of blood glucose levels. Once the blood glucose level has been detected, the implanted device compares the blood glucose level against upper and lower acceptable bounds and appropriate warning signals are generated if the level falls outside the bounds. In one example, wherein an implantable insulin pump is additionally provided, the pump is controlled based on the detected blood glucose level to maintain glucose levels within an acceptable range. A calibration technique is also provided for determining patient-specific parameters for use in the detection of blood glucose levels.
    Type: Grant
    Filed: October 21, 2002
    Date of Patent: April 18, 2006
    Assignee: Pacesetter, Inc.
    Inventor: Mark W. Kroll
  • Patent number: 7024243
    Abstract: Various techniques are described for preventing pacemaker mediated tachycardia (PMT) within biventricular pacing systems and for detecting and terminating PMT should it nevertheless arise. In a first prevention technique, refractory periods applied to the atrial channel are synchronized to begin with a second of a pair of ventricular pacing pulses to more effectively prevent T-wave oversensing on the atrial channel. In a second prevention technique, the sensitivity of the atrial channel is reduced during T-waves also to prevent T-wave oversensing. In a third prevention technique, template matching is performed on the ventricular channels to prevent T-wave oversensing. In a fourth prevention technique, T-wave detection windows are applied to both the ventricular and atrial channels subsequent to any paced or sensed events. In a first detection technique, PMT is detected based upon a degree of variation within V-pulse to P-wave pacing intervals.
    Type: Grant
    Filed: February 13, 2003
    Date of Patent: April 4, 2006
    Assignee: Pacesetter, Inc.
    Inventors: Gene A. Bornzin, Mark W. Kroll
  • Patent number: 6968233
    Abstract: A system and method for use in an implantable cardiac stimulation device permits automatic induction of a tachyarrhythmia of a heart to permit the performance of an electrophysiological test of the heart. A pulse generator repeatedly delivers a group of first and second sets of pacing pulses to a chamber of the heart. The pacing pulses are separated in time by interpulse intervals to overdrive pace a chamber of the heart. A processor, coupled to the pulse generator, varies the second set of interpulse intervals according to a predetermined protocol after each group of pacing pulses is delivered to the chamber of the heart. The successive groups of pacing pulses are delivered to the heart until the tachyarrhythmia is induced.
    Type: Grant
    Filed: June 20, 2002
    Date of Patent: November 22, 2005
    Assignee: Pacesetter, Inc.
    Inventors: John Thomas Parry, Gary Robert Viviano, James Edward Gantz, Jr.